Skip to main content
. 2017 Jul 10;12(7):e0180641. doi: 10.1371/journal.pone.0180641

Table 1. Descriptive data of the two cohorts.

Cohort 1 Cohort 2
N = 364 N = 332
Characteristic
Background data
Age, median (IQR) 84 (79–88) 85 (78–89)
Female, n/N (%) 276/364 (76) 252/332 (76)
Prefracture Barthel Index score, median (IQR) 19 (16–20) 18 (14–20)
Nottingham EADL, median (IQR) 39 (17–56) 30(10–52)
Prefracture dementia (consensus diagnosis), n/N (%) 65/171 (38) 165/332 (50)
IQCODE score, median (IQR) 3.44 (3.06–4.50) 3.75 (3.06–4.81)
Living in an institution, n/N (%) 56/364 (15) 104/332 (31)
Injury occurred indoors, n/N (%) 259/361 (72) 277/332 (83)
Prefracture hypertension, n/N (%) 121/364 (33) 136/315 (43)
Charlson comorbidity index > 1, n/N (%) 107/364 (29) 108/332 (33)
Polypharmacy (= 5 or more systemic medications), n/N (%) 140/364 (39) 159/332 (48)
BMI, median (IQR)b 22 (20–25) 24 (21–27)
Admission data
Time admission to surgery, hours, median (IQR) 18 (9–29) 24 (16–40)
CRP > 10 mg/L, n/N (%) 129/364 (35) 130/328 (40)
ASA group III, IV or V, n/N (%) 181/363 (50) 191/306 (62)
Spinal anaesthesia, n/N (%) 337/362 (93) 291/315 (92)
Surgery started between 5:00 p.m. and 6:30 a.m. 153/360 (43) 156/328 (48)
Sepsis, n/N (%) 5/364 (1) 4/332 (1)
Stroke, n/N (%) 3/364 (1) 1/332 (0)
Delirium any time during hospital stay 168/364 (46) 168/327 (51)
Preoperative delirium 50/237 (21) 99/299 (33)
Incident delirium 68/187 (36) 56/200 (26)

IQR = Interquartile range; Nottingham EADL = Nottingham Extended Activities of Daily Living; IQCODE = Informant Questionnaire on Cognitive Decline in the Elderly; BMI = Body Mass Index; CRP = C-reactive protein; ASA = American Society of Anaesthesiologists

Missing data (N) for several variables: Prefracture dementia consensus diagnosis: N = 193, Injury occurred indoors: N = 3, Prefracture hypertension: N = 17, BMI: N = 134, CRP: N = 4, ASA group: N = 27, Spinal anaesthesia: N = 19, Time of surgery: N = 8, Delirium any time: N = 5, Preoperative delirium assessments: N = 160 (127 in cohort 1 and 33 in cohort 2).